首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Histamine modulates contraction and cyclic nucleotides in cultured rat mesangial cells. Differential effects mediated by histamine H1 and H2 receptors.
【2h】

Histamine modulates contraction and cyclic nucleotides in cultured rat mesangial cells. Differential effects mediated by histamine H1 and H2 receptors.

机译:组胺调节培养的大鼠系膜细胞的收缩和环状核苷酸。组胺H1和H2受体介导的差异作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Histamine influences the glomerular microcirculation and modulates immune-inflammatory responses. In the rat kidney, histamine is synthesized by glomeruli and stimulates cyclic nucleotide production specifically in glomeruli. We investigated the in vitro effect of histamine on cyclic nucleotide accumulation in rat cultured glomerular mesangial and epithelial cells. Histamine stimulated cyclic AMP (cAMP) accumulation in cultured mesangial cells (64.0 +/- 22.1 to 511.4 +/- 86.6 pmol/mg protein, n = 9) but had no effect on cAMP accumulation in epithelial cells. This effect was dose-dependent and time-dependent. Stimulation of cAMP accumulation occurred in the range of 5 X 10(-6) M-10(-4) M histamine with a half maximal stimulatory effect of 2 X 10(-5) M. Initial stimulation was noted by 30 s, and maximum stimulation was observed at 5 min. The H2 antagonist cimetidine (10(-4) M) abolished the stimulatory effect of histamine (10(-4) M), while equimolar concentrations of the H1 antagonist diphenhydramine had no significant effect on cAMP accumulation. Moreover, the specific H2 agonist dimaprit, but not the H1 agonist 2-pyridylethylamine, stimulated cAMP accumulation. Histamine had no effect on cAMP accumulation in epithelial cells or on cyclic guanosine monophosphate accumulation in epithelial or mesangial cells. Since the in vivo infusion of histamine reduces ultrafiltration coefficient and since mesangial cell contraction is thought to be responsible for the reduction in the ultrafiltration coefficient, we examined the effect of histamine on the contractile property of mesangial cells. Histamine (5 X 10(-6)-10(-4) M) contracted mesangial cells, and the H1 antagonist diphenhydramine (10(-4) M) but not the H2 antagonist cimetidine (10(-4) M) prevented histamine (10(-4) M) induced contraction. In addition, the H1 agonist 2-pyridylethylamine, but not the H2 agonist dimaprit, contracted mesangial cells. Histamine and its specific agonists and antagonists induced contraction of isolated glomeruli as assessed by glomerular planar surface area in a manner parallel to their effect on mesangial cells. Cinnarizine (10(-5) M), a Ca++ channel blocker, or Ca++, Mg++-free medium prevented histamine (10(-4) M) induced mesangial cell and glomerular contraction. Thus, histamine enhances cAMP accumulation specifically in mesangial cells via an H2 receptor. In contrast, histamine contracts mesangial cells and glomeruli via an H1 receptor, an effect that is dependent on extracellular Ca++ entry. These findings show that histamine potentially influences intraglomerular hemodynamics via effects on mesangial cell contraction. Moreover, our findings considered with the in vivo observation that histamine reduces kf via and H1 receptor provide further support of the hypothesis that mesangial cell contraction regulates the glomerular capillary surface area available for filtration. Our studies also show that this contractile effect of histamine is dependent on extracellular calcium. The presence of a cAMP system sensitive to histamine may have major implications in the pathogenesis of inflammatory glomerulopathies. Mesangial cells possess characteristics similar to circulating and tissue immune effector cells, including lysosomal enzyme release, oxygen radical production, and release of a number of immunomodulatory factors. Histamine and cAMP have been shown to modulate such characteristics of inflammatory cells. It is therefore conceivable that histamine, via its interaction with H2 receptors and subsequent generation cAMP, may have profound effects on such properties of mesangial cells, suggesting that this autacoid may modulate not only glomerular hemodynamics but also immune, inflammatory responses within the glomerulus.
机译:组胺影响肾小球的微循环并调节免疫炎症反应。在大鼠肾脏中,组胺由肾小球合成,并特异性刺激肾小球中环状核苷酸的产生。我们调查了组胺对大鼠培养的肾小球系膜和上皮细胞中环核苷酸积累的体外影响。组胺刺激培养的系膜细胞中环AMP(cAMP)的积累(64.0 +/- 22.1至511.4 +/- 86.6 pmol / mg蛋白,n = 9),但对上皮细胞中cAMP的积累没有影响。该作用是剂量依赖性和时间依赖性的。 cAMP积累的刺激发生在5 X 10(-6)M-10(-4)M组胺的范围内,最大刺激作用为2 X 10(-5)M。开始刺激的时间为30 s,并且在5分钟时观察到最大刺激。 H2拮抗剂西咪替丁(10(-4)M)取消了组胺(10(-4)M)的刺激作用,而等摩尔浓度的H1拮抗剂苯海拉明对cAMP的积累没有显着影响。此外,特定的H2激动剂dimaprit,而不是H1激动剂2-吡啶基乙胺刺激了cAMP的积累。组胺对上皮细胞中cAMP的积累或上皮或系膜细胞中环状鸟苷单磷酸的积累没有影响。由于在体内输注组胺会降低超滤系数,并且由于认为系膜细胞收缩是导致超滤系数降低的原因,因此我们研究了组胺对系膜细胞收缩特性的影响。组胺(5 X 10(-6)-10(-4)M)收缩系膜细胞,H1拮抗剂苯海拉明(10(-4)M)但H2拮抗剂西咪替丁(10(-4)M)不能阻止组胺(10(-4)M)引起收缩。另外,H1激动剂2-吡啶基乙胺而不是H2激动剂双马普利使肾小球膜细胞收缩。组胺及其特异性激动剂和拮抗剂以与肾小球膜细胞作用平行的方式诱导了肾小球的收缩,这是通过肾小球平面表面积评估的。 Cinnarizine(10(-5)M),一种Ca ++通道阻滞剂,或不含Ca ++,无Mg ++的培养基可防止组胺(10(-4)M)诱导系膜细胞和肾小球收缩。因此,组胺通过H 2受体特异性地增强了cAMP在肾小球膜细胞中的积累。相反,组胺通过H1受体收缩肾小球膜细胞和肾小球,这种作用取决于细胞外Ca ++的进入。这些发现表明,组胺可能通过影响肾小球膜细胞收缩而影响肾小球内血流动力学。此外,我们的发现与体内观察结果一起考虑,即组胺通过和H1受体降低kf,为肾小球系膜细胞收缩调节可用于过滤的肾小球毛细血管表面积的假说提供了进一步的支持。我们的研究还表明,组胺的这种收缩作用取决于细胞外钙。对组胺敏感的cAMP系统的存在可能对炎症性肾小球病的发病机制有重要影响。肾小球膜细胞具有与循环和组织免疫效应细胞相似的特征,包括溶酶体酶释放,氧自由基产生以及许多免疫调节因子的释放。组胺和cAMP已被证明可调节炎症细胞的这种特征。因此,可以想象的是,组胺通过其与H2受体的相互作用以及随后产生的cAMP,可能对系膜细胞的这种特性产生深远的影响,这表明该类胡萝卜素不仅可以调节肾小球的血流动力学,而且可以调节肾小球内的免疫炎症反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号